Japan

News from aidsmap

• Atazanavir/ritonavir more likely to cause kidney stones than other ritonavir-boosted protease inhibitors

  Kidney problems
  Michael Carter | 29 August 2012

  Treatment with ritonavir-boosted atazanavir is associated with a much higher risk of kidney stones compared to other ritonavir-boosted protease inhibitors, Japanese investigators report in the online edition of the Journal of Acquired Immune Deficiency ...

• Some gay men should be allowed to give blood, argue Canadian researchers

  Michael Carter | 26 May 2010

  HIV-negative gay men who have been in a stable, monogamous relationship for at least one year should be allowed to give blood, a team of Canadian investigators argue in the ...

• IL28B gene variation predicts response to hepatitis C treatment: will it change treatment of co-infection?

  Hepatitis and HIV
  Liz Highleyman | 01 March 2010

  Variations in the IL28B gene that have recently been linked to better treatment response among people with chronic hepatitis C virus (HCV) infection may also predict recovery in HIV/HCV-coinfected people, ...

• Genetic marker predicts fat loss due to d4T in Thai patients

  Side-effects
  Keith Alcorn | 26 January 2010

  A genetic marker can predict with a high level of accuracy whether Thai patients receiving antiretroviral therapy that contains d4T (stavudine) will develop lipoatrophy (subcutaneous fat loss) as a result ...

• Asian gay men’s sex survey reports high levels of sex without condoms

  Epidemiology
  Gus Cairns | 13 January 2010

  The world’s second-largest sex survey of men who have sex with men, focusing mainly on men in East and Southeast Asia, has found that 46% of those who had anal ...

• International donors must not retreat from commitment to HIV treatment scale-up, MSF warns

  HIV treatment
  Keith Alcorn | 06 November 2009

  A retreat from international funding commitments for AIDS threatens to undermine the dramatic gains made in reducing AIDS-related illness and death in recent years, according to a new report by ...

• Efavirenz dose reduction safe for patients with gene associated with high drug levels and side-effects

  Side-effects
  Michael Carter | 12 March 2009

  Doses of efavirenz (Sustiva) can be safely reduced by up to two-thirds in patients who develop side-effects if these are due to a genetic mutation resulting in high concentrations of ...

• Doubt cast on cost-effectiveness of HLA-B*5701 screening for Asian patients

  Health monitoring
  Michael Carter | 09 January 2009

  No HIV-positive Korean patients tested positive for the gene associated with hypersensitivity to abacavir (Ziagen), investigators report in the February 1st edition of Clinical Infectious Diseases. The study supports other ...